The Journal of Heart and Lung Transplantation
Volume 29, Issue 6 , Pages 603-609 , June 2010

Reversal of impaired myocardial β-adrenergic receptor signaling by continuous-flow left ventricular assist device support

  • Shahab A. Akhter, MD

      Affiliations

    • Department of Surgery, Section of Cardiac and Thoracic Surgery, University of Chicago Medical Center, Chicago, Illinois
    • Corresponding Author InformationReprint requests: Shahab A. Akhter, MD, University of Chicago Medical Center, 5841 S Maryland Ave, MC 5040, Chicago, IL 60637. Telephone: 773-702-2500; Fax: 773-702-4187
    • ,
  • Karen M. D'Souza, PhD

      Affiliations

    • Department of Surgery, Section of Cardiac and Thoracic Surgery, University of Chicago Medical Center, Chicago, Illinois
    • ,
  • Ricky Malhotra, PhD

      Affiliations

    • Department of Surgery, Section of Cardiac and Thoracic Surgery, University of Chicago Medical Center, Chicago, Illinois
    • ,
  • Michelle L. Staron, BS

      Affiliations

    • Department of Surgery, Section of Cardiac and Thoracic Surgery, University of Chicago Medical Center, Chicago, Illinois
    • ,
  • Tracy B. Valeroso, RN, MSN

      Affiliations

    • Department of Surgery, Section of Cardiac and Thoracic Surgery, University of Chicago Medical Center, Chicago, Illinois
    • ,
  • Savitri E. Fedson, MD

      Affiliations

    • Department of Medicine, Section of Cardiology, University of Chicago Medical Center, Chicago, Illinois
    • ,
  • Allen S. Anderson, MD

      Affiliations

    • Department of Medicine, Section of Cardiology, University of Chicago Medical Center, Chicago, Illinois
    • ,
  • Jai Raman, MD, PhD

      Affiliations

    • Department of Surgery, Section of Cardiac and Thoracic Surgery, University of Chicago Medical Center, Chicago, Illinois
    • ,
  • Valluvan Jeevanandam, MD

      Affiliations

    • Department of Surgery, Section of Cardiac and Thoracic Surgery, University of Chicago Medical Center, Chicago, Illinois

References 

  1. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205–211
  2. Brodde OE, Michel MC, Zerkowski HR. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res. 1995;30:570–584
  3. Inglese J, Freedman NJ, Koch WJ, et al. Structure and mechanism of the G protein-coupled receptor kinases. J Biol Chem. 1993;268:23735–23738
  4. Ungerer M, Parruti G, Bohm M, et al. Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res. 1994;74:206–213
  5. Ungerer M, Bohm M, Elce JS, et al. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 1993;87:454–463
  6. Akhter SA, Skaer CA, Kypson AP, et al. Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci U S A. 1997;94:12100–12105
  7. Rengo G, Lymperopoulos A, Zincarelli C, et al. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation. 2009;119:89–98
  8. Raake PW, Vinge LE, Gao E, et al. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ Res. 2008;103:413–422
  9. Akhter SA, Eckhart AD, Rockman HA, et al. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function. Circulation. 1999;100:648–653
  10. Pandalai PK, Bulcao CF, Merrill WH, et al. Restoration of myocardial β-adrenergic receptor signaling following left ventricular assist device support. J Thorac Cardiovasc Surg. 2006;131:975–980
  11. Heerdt PM, Holmes JW, Cai B, et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation. 2000;102:2713–2719
  12. James KB, McCarthy PM, Thomas JD, et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation. 1995;92:II191–II195
  13. Akhter SA, D'Souza KM, Petrashevskaya NN, et al. Myocardial β1-adrenergic receptor polymorphisms affect functional recovery following ischemic injury. Am J Physiol Heart Circ Physiol. 2006;290:H1427–H1432
  14. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974;58:541–548
  15. Iaccarino G, Barbato E, Cipolletta E, et al. Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J. 2005;26:1752–1758
  16. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature. 2002;415:206–212
  17. Freedman NJ, Liggett SB, Drachman DE, et al. Phosphorylation and desensitization of the human β1-adrenergic receptor: involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. J Biol Chem. 1995;270:17953–17961
  18. Koch WJ, Inglese J, Stone WC, et al. The binding site for the βγ subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase. J Biol Chem. 1993;268:8256–8260
  19. Eckhart AD, Duncan SJ, Penn RB, et al. Hybrid transgenic mice reveal in vivo specificities of G protein-coupled receptor kinases in the heart. Circ Res. 2000;86:43–50
  20. Koch WJ, Rockman HA, Samama P, et al. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science. 1995;268:1350–1353
  21. White DC, Hata JA, Shah AS, et al. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc Natl Acad Sci U S A. 2000;97:5428–5433
  22. Rockman HA, Chien KR, Choi DJ, et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A. 1998;95:7000–7005
  23. Pleger ST, Boucher M, Most P, Koch WJ. Targeting myocardial β-adrenergic receptor signaling and calcium cycling for heart failure gene therapy. J Cardiac Fail. 2007;13:401–414
  24. Kypson AP, Peppel K, Akhter SA, et al. Ex Vivo adenovirus-mediated gene transfer to the adult rat heart. J Thorac Cardiovasc Surg. 1998;115:623–630
  25. Brodde OE. Beta-adrenoceptors in cardiac disease. Pharmac Ther. 1993;60:405–430
  26. Haft J, Armstrong W, Dyke DB, et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation. 2007;116(suppl I):8–15
  27. Thohan V, Stetson SJ, Nagueh SF, et al. Cellular and hemodynamic responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant. 2005;24:566–575

PII: S1053-2498(10)00042-2

doi: 10.1016/j.healun.2010.01.010

The Journal of Heart and Lung Transplantation
Volume 29, Issue 6 , Pages 603-609 , June 2010

Article Tools

* Image Usage & Resolution